San Diego, CA, United States of America

Srinivasa Ready Natala

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivasa Ready Natala. Retrieved from https://idiyas.com/inventor/srinivasa-ready-natala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Srinivasa Ready Natala

Introduction

Srinivasa Ready Natala is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. His work has the potential to impact various therapeutic areas.

Latest Patents

Srinivasa Ready Natala holds a patent for Polo-like kinase inhibitors. The patent describes compounds that are useful with kinases, where the variables are defined within the document. Additionally, it includes pharmaceutical compositions, kits, and articles of manufacture that comprise such compounds. The patent also outlines methods and intermediates useful for making these compounds, as well as methods of using them.

Career Highlights

Srinivasa Ready Natala is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His role involves research and development in innovative therapeutic solutions. His expertise in kinase inhibitors showcases his commitment to advancing medical science.

Collaborations

Srinivasa has collaborated with notable colleagues, including Sheldon Cao and Victoria Feher. These partnerships enhance the research environment and foster innovation within the pharmaceutical industry.

Conclusion

Srinivasa Ready Natala's contributions to the field of pharmaceuticals, particularly through his patent on Polo-like kinase inhibitors, highlight his role as a significant inventor. His work at Takeda Pharmaceutical Company Limited and collaborations with esteemed colleagues further emphasize his impact on medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…